Cipla

India's Cipla gets approval to import Moderna's COVID-19 vaccine for restricted emergency use

June 29, 2021

India's Cipla gets approval to import Moderna's COVID-19 vaccine for restricted emergency use

Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.

July 25, 2020
Cipla gets DGCI approval to sell COVID-19 drug favipiravir

Indian drugmakers including Glenmark Pharmaceuticals Ltd are racing to supply generic versions of favipiravir, originally developed by Japan's Fujifilm Holdings Corp as Avigan for treating influenza.
May 13, 2020
Cipla, Jubilant Life, Hetero, Mylan ink licensing pact with Gilead for remdesivir

The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat COVID-19 patients.